Cargando…

Cystatin C Predicts Incident Cardiovascular Disease in Twins

BACKGROUND: Cystatin C is associated with both renal function and atherosclerotic cardiovascular disease (ASCVD). We have previously shown a genetic correlation between cystatin C and prevalent ASCVD. The objective of this article is to study whether variation in cystatin C or creatinine predicts in...

Descripción completa

Detalles Bibliográficos
Autores principales: Arpegård, Johannes, Magnusson, Patrik K. E., Chen, Xu, Ridefelt, Peter, Pedersen, Nancy L., De Faire, Ulf, Svensson, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937258/
https://www.ncbi.nlm.nih.gov/pubmed/27353608
http://dx.doi.org/10.1161/JAHA.115.003085
_version_ 1782441676586876928
author Arpegård, Johannes
Magnusson, Patrik K. E.
Chen, Xu
Ridefelt, Peter
Pedersen, Nancy L.
De Faire, Ulf
Svensson, Per
author_facet Arpegård, Johannes
Magnusson, Patrik K. E.
Chen, Xu
Ridefelt, Peter
Pedersen, Nancy L.
De Faire, Ulf
Svensson, Per
author_sort Arpegård, Johannes
collection PubMed
description BACKGROUND: Cystatin C is associated with both renal function and atherosclerotic cardiovascular disease (ASCVD). We have previously shown a genetic correlation between cystatin C and prevalent ASCVD. The objective of this article is to study whether variation in cystatin C or creatinine predicts incident ASCVD when controlled for genetic factors. METHODS AND RESULTS: The predictive value of cystatin C and creatinine for incident ASCVD was studied in 11 402 Swedish twins, free of CVD at baseline, in an adjusted Cox‐regression model during a median follow‐up of 71 months. Twin pairs discordant for incident stroke, myocardial infarction and ASCVD during follow‐up were identified and within‐pair comparisons regarding cystatin C and creatinine levels were performed. We also investigated whether contact frequency and degree of shared environment influences were associated with similarity in cystatin C levels. In univariate analysis, cystatin C predicted incident ASCVD hazard ratio 1.57, 95% CI 1.47–1.67. When adjusted for traditional Framingham risk factors as covariates, cystatin C remained a predictor of incident stroke hazard ratio 1.45, 95% CI (1.25–1.70), ASCVD hazard ratio 1.26, 95% CI (1.13–1.41), and myocardial infarction hazard ratio 1.16, 95% CI (1.01–1.33). In twins discordant for incident stroke, cystatin C at baseline was higher in the twin who experienced a stroke compared to the healthy co‐twin (1.11±0.3 mg/L versus 1.06±0.3 mg/L), whereas creatinine was lower in the twin who developed CVD compared to their healthy co‐twins (76.1±16.9 μmol/L versus 79.4±20.3 μmol/L). CONCLUSIONS: Variation in cystatin C relates to incident ASCVD and to stroke when adjusted for genetic confounding. In identical twins, cystatin C may be a sensitive marker of early hypertensive end‐organ damage and small‐vessel disease, whereas creatinine level may reflect nutritional status. The findings in disease‐discordant monozygotic twins indicate that unique, possibly preventable, environmental factors are important.
format Online
Article
Text
id pubmed-4937258
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-49372582016-07-18 Cystatin C Predicts Incident Cardiovascular Disease in Twins Arpegård, Johannes Magnusson, Patrik K. E. Chen, Xu Ridefelt, Peter Pedersen, Nancy L. De Faire, Ulf Svensson, Per J Am Heart Assoc Original Research BACKGROUND: Cystatin C is associated with both renal function and atherosclerotic cardiovascular disease (ASCVD). We have previously shown a genetic correlation between cystatin C and prevalent ASCVD. The objective of this article is to study whether variation in cystatin C or creatinine predicts incident ASCVD when controlled for genetic factors. METHODS AND RESULTS: The predictive value of cystatin C and creatinine for incident ASCVD was studied in 11 402 Swedish twins, free of CVD at baseline, in an adjusted Cox‐regression model during a median follow‐up of 71 months. Twin pairs discordant for incident stroke, myocardial infarction and ASCVD during follow‐up were identified and within‐pair comparisons regarding cystatin C and creatinine levels were performed. We also investigated whether contact frequency and degree of shared environment influences were associated with similarity in cystatin C levels. In univariate analysis, cystatin C predicted incident ASCVD hazard ratio 1.57, 95% CI 1.47–1.67. When adjusted for traditional Framingham risk factors as covariates, cystatin C remained a predictor of incident stroke hazard ratio 1.45, 95% CI (1.25–1.70), ASCVD hazard ratio 1.26, 95% CI (1.13–1.41), and myocardial infarction hazard ratio 1.16, 95% CI (1.01–1.33). In twins discordant for incident stroke, cystatin C at baseline was higher in the twin who experienced a stroke compared to the healthy co‐twin (1.11±0.3 mg/L versus 1.06±0.3 mg/L), whereas creatinine was lower in the twin who developed CVD compared to their healthy co‐twins (76.1±16.9 μmol/L versus 79.4±20.3 μmol/L). CONCLUSIONS: Variation in cystatin C relates to incident ASCVD and to stroke when adjusted for genetic confounding. In identical twins, cystatin C may be a sensitive marker of early hypertensive end‐organ damage and small‐vessel disease, whereas creatinine level may reflect nutritional status. The findings in disease‐discordant monozygotic twins indicate that unique, possibly preventable, environmental factors are important. John Wiley and Sons Inc. 2016-06-27 /pmc/articles/PMC4937258/ /pubmed/27353608 http://dx.doi.org/10.1161/JAHA.115.003085 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Arpegård, Johannes
Magnusson, Patrik K. E.
Chen, Xu
Ridefelt, Peter
Pedersen, Nancy L.
De Faire, Ulf
Svensson, Per
Cystatin C Predicts Incident Cardiovascular Disease in Twins
title Cystatin C Predicts Incident Cardiovascular Disease in Twins
title_full Cystatin C Predicts Incident Cardiovascular Disease in Twins
title_fullStr Cystatin C Predicts Incident Cardiovascular Disease in Twins
title_full_unstemmed Cystatin C Predicts Incident Cardiovascular Disease in Twins
title_short Cystatin C Predicts Incident Cardiovascular Disease in Twins
title_sort cystatin c predicts incident cardiovascular disease in twins
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937258/
https://www.ncbi.nlm.nih.gov/pubmed/27353608
http://dx.doi.org/10.1161/JAHA.115.003085
work_keys_str_mv AT arpegardjohannes cystatincpredictsincidentcardiovasculardiseaseintwins
AT magnussonpatrikke cystatincpredictsincidentcardiovasculardiseaseintwins
AT chenxu cystatincpredictsincidentcardiovasculardiseaseintwins
AT ridefeltpeter cystatincpredictsincidentcardiovasculardiseaseintwins
AT pedersennancyl cystatincpredictsincidentcardiovasculardiseaseintwins
AT defaireulf cystatincpredictsincidentcardiovasculardiseaseintwins
AT svenssonper cystatincpredictsincidentcardiovasculardiseaseintwins